We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
1Assistant Professor, Department of Pharmacy practice, Shantha College of Pharmacy, Peresendra, Chikkaballapur, Karnataka – 562104
2Shantha College of Pharmacy, Peresendra, Chikkaballapur – 562104
3Assistant Professor, Department of Pharmacology, Shantha College of Pharmacy, Peresendra, Chikkaballapur – 562104
4Assistant professor, Department of Pharmaceutics, Shantha College of Pharmacy, Peresendra, Chikkaballapur – 562104
5Principal, Department of Pharmaceutics, Shantha College of Pharmacy, Peresendra, Chikkaballapur – 562104
Diabetes mellitus (DM) is a chronic, progressive metabolic disorder characterized by persistent hyperglycemia arising from impaired insulin secretion, peripheral insulin resistance, or a combination of both defects. Among its numerous micro- and macrovascular sequelae, diabetic retinopathy (DR) constitutes one of the foremost causes of preventable blindness in the working-age population worldwide. Conventional pharmacotherapy, comprising insulin replacement, oral hypoglycemic agents and anti-vascular endothelial growth factor (anti-VEGF) intravitreal therapy, is frequently limited by cumulative toxicity, high cost, and an inability to fully arrest disease progression. Consequently, plant-derived phytoconstituents, particularly flavonoids, have attracted considerable scientific interest as multi-targeted therapeutic alternatives. Couroupita guianensis Aubl. is a tropical medicinal plant whose flowers, leaves and bark are rich in bioactive flavonoids such as quercetin, kaempferol, rutin, luteolin and pelargonidin glycosides. These constituents have been reported to exert antidiabetic effects through inhibition of carbohydrate-hydrolyzing enzymes, free-radical scavenging, suppression of pro-inflammatory signaling, protection of pancreatic β-cells, and attenuation of the oxidative and angiogenic pathways implicated in diabetic retinopathy. This review consolidates current knowledge of the phytochemical profile, molecular mechanisms, retino-protective pathways and translational prospects of flavonoid-rich Couroupita guianensis extracts, with the aim of supporting their further development as adjunct or alternative agents in the management of diabetes and its ocular complications.
Diabetes mellitus represents one of the most rapidly expanding non-communicable diseases globally, with prevalence projected to rise substantially over the coming decades as a consequence of sedentary lifestyles, and increasing obesity rates. The disorder is characterized not merely by elevated blood glucose but by a constellation of downstream biochemical derangements that progressively damage multiple organ systems. Chronic hyperglycemia is now well recognized as the principle driver of both macrovascular complications, such as coronary artery disease and stroke, and microvascular complications, including nephropathy, neuropathy, and retinopathy. Among these, diabetic retinopathy remains a leading cause of irreversible vision loss in adults of working age.
Fig. No. 1: Pathophysiology of Diabetes mellitus
The pathogenesis of diabetic retinopathy is multifactorial and involves the convergence of several interrelated biochemical cascades. Sustained hyperglycemia promotes excessive generation of reactive oxygen species (ROS), activation of pro-inflammatory cytokine pathways, mitochondrial dysfunction, accumulation of advanced glycation end-products (AGEs), and progressive structural damage to the retinal microvasculature. These processes act synergistically rather than in isolation, producing a self-perpetuating cycle of oxidative and inflammatory injury that culminates in capillary occlusion, neovascularization, and, ultimately, vision-threatening complications such as macular oedema and vitreous hemorrhage. Current management strategies for diabetes and its ocular complications are largely centered on insulin therapy, oral hypoglycemic agents, and, in advanced retinopathy, anti-VEGF intravitreal injections or laser photocoagulation. While effective in controlling glycaemia and slowing disease progression, these interventions are frequently associated with long-term adverse effects, considerable financial cost, and an inability to completely halt the underlying pathological process. Such limitations have intensified interest in plant-derived bioactive compounds as complementary or alternative therapeutic strategies. Flavonoids, a structurally diverse class of polyphenolic phytochemicals, have emerged as particularly promising candidates owing to their capacity to simultaneously modulate several of the biochemical pathways implicated in diabetes pathogenesis and retinal damage, including enzyme inhibition, antioxidant defense, anti-inflammatory signaling, and anti-angiogenic activity. Couroupita guianensis, a medicinal plant with a long history of traditional use, and examines the phytochemical basis, mechanistic pathways, and preclinical pharmacological evidence supporting its potential application in the management of diabetes mellitus and diabetic retinopathy. The review further outlines existing research gaps and proposes directions for future investigation to facilitate the translational development of this botanical resource.
Botanical Description Of Couroupita Guianensis
Fig. No. 2: Leaves & flowers of Couroupita guianensis Aubl.
Fig. No. 3: Fruit of Couroupita guianensis Aubl.
Geographical Distribution and Traditional Use
Taxonomical Study of Couroupita Guianensis Aubl
Table. No. 1: Taxonomical classification of Couroupita guianensis Aubl.
|
Taxonomical Rank |
Classification |
|
Kingdom |
Plantae |
|
Sub-kingdom |
Tracheobionta (Vascular plants) |
|
Division |
Magnoliophyte (Flowering plants) |
|
Class |
Magnoliopsida (Dicotyledons) |
|
Order |
Ericales |
|
Family |
Lecythidaceae |
|
Genus |
Couroupita |
|
Species |
Couroupita guianensis Aubl |
It’s commonly known as Cannon Ball Tree
Synonyms: Ayahuma, Sala Tree (in some regions)
Phytochemical Composition of Couroupita Guianensis
Phytochemical screening of various parts of Couroupita guianensis has revealed a chemically diverse profile comprising flavonoids, phenolic acids, alkaloids, sterols, and several minor bioactive constituents. The phytochemical profile of C. guianensis varies considerably across plant organs, reflecting tissue-specific biosynthetic activity.
Table. No. 2: Phytochemical Composition of C. guianensis
|
Phytochemical Class |
Representative Compounds Identified |
|
Flavonoids |
Quercetin, kaempferol, rutin, luteolin |
|
Phenolic acids |
Rosmarinic acid, caffeic acid |
|
Alkaloids |
Couroupitine |
|
Sterols |
β-Sitosterol, campesterol |
|
Other constituents |
Isatin, indirubin, tryptanthrin |
The therapeutic potential of Couroupita guianensis is largely attributed to its flavonoid-rich composition. Flavonoids are low-molecular-weight polyphenolic compounds characterized by a common diphenyl propane (C6–C3–C6) skeleton, which confers strong antioxidant, enzyme-modulatory, and anti-inflammatory properties. By virtue of their phenolic hydroxyl groups, these compounds function as potent free-radical scavengers capable of neutralizing reactive oxygen and nitrogen species generated during states of metabolic stress. In addition, several flavonoid constituents have been shown to interact with key enzymes and signaling intermediates involved in glucose homeostasis, thereby contributing to their observed antidiabetic activity. The co-occurrence of phenolic acids, sterols, and alkaloid derivatives may further contribute synergistically to the overall pharmacological profile of the plant, although the relative contribution of each compound class warrants further isolation-based investigation.
Flavonoids as Antidiabetic Agents
Oxidative Stress and Diabetes Pathophysiology
Persistent hyperglycemia is a potent stimulus for the excessive generation of reactive oxygen species through several interconnected biochemical routes, including mitochondrial electron transport chain dysfunction, auto-oxidation of glucose, and activation of the polyol and protein kinase C pathways. The resultant state of oxidative stress, defined as an imbalance between pro-oxidant generation and antioxidant defense capacity, contributes to widespread cellular injury. Specific consequences include direct oxidative damage to nuclear and mitochondrial DNA, peroxidative degradation of membrane lipids, oxidative modification of structural and functional proteins, induction of programmed cell death (apoptosis), and progressive endothelial dysfunction, the latter being a critical early event in the development of diabetic vascular complications. Flavonoids counteract this oxidative burden through multiple, mutually reinforcing antioxidant mechanisms. At the molecular level, the phenolic hydroxyl groups present on the flavonoid backbone are capable of directly donating hydrogen atoms or electrons to neutralize free radicals, thereby terminating chain-propagating oxidative reactions. In addition, several flavonoids chelate transition metal ions such as iron and copper, which would otherwise catalyze the generation of highly reactive hydroxyl radicals via Fenton-type chemistry. Beyond their direct radical-scavenging properties, certain flavonoids have also been implicated in the upregulation of endogenous antioxidant defense systems, including enzymes regulated through the Nrf2 signaling pathway, further amplifying their cytoprotective potential against hyperglycemia-induced oxidative injury.
Pathophysiology of Diabetic Retinopathy
Diabetic retinopathy develops as a consequence of chronic hyperglycemia-induced microvascular injury within the retinal vasculature, mediated through a cascade of interrelated molecular pathways. As outlined schematically below, sustained hyperglycemia initiates excessive reactive oxygen species generation, which in turn promotes the formation of advanced glycation end-products. These AGEs interact with their cognate receptor (RAGE) to activate protein kinase C (PKC) and nuclear factor-kappa B (NF-κB) signaling cascades, culminating in the overexpression of vascular endothelial growth factor (VEGF). Elevated VEGF activity disrupts the integrity of the blood-retinal barrier, leading to vascular leakage, retinal oedema, and, in advanced stages, pathological neovascularization and consequent vision loss.
Hyperglycemia
ROS generation
AGE formation
PKC activation
NF-κB activation
VEGF overexpression
Retinal vascular leakage (Vision loss)
Several discrete but interconnected molecular pathways have been implicated in the pathogenesis of diabetic retinopathy:
Fig. No. 5: Pathophysiology of Diabetic retinopathy
Role of Flavonoids In Diabetic Retinopathy Treatment
Given the multifactorial pathophysiology of diabetic retinopathy described above, flavonoids are particularly well suited as therapeutic candidates owing to their capacity to act simultaneously at several points within the disease cascade.
Artificial Intelligence in Early Detection of Diabetic Retinopathy
Parallel to advances in phototherapeutic research, the application of artificial intelligence and machine learning methodologies has emerged as a transformative approach for the early and automated diagnosis of diabetic retinopathy from fundus photography. Hybrid computational frameworks combining deep learning architectures with optimisation-based feature selection have demonstrated considerable diagnostic promise. For example, models integrating a Restricted Boltzmann Machine for feature extraction, threshold-based U-Net architecture for retinal lesion segmentation, and a Squirrel Search Algorithm for parameter optimization have been reported to achieve diagnostic accuracies approaching 99.2%, accompanied by high specificity and improved detection of subtle retinal abnormalities relative to conventional screening approaches. While such computational tools and the phytopharmacological strategies distinct domains of investigation, their convergence holds considerable translational promise. Artificial intelligence-based screening platforms could, in principle, facilitate earlier identification of at-risk patients, enabling timely initiation of adjunct phototherapeutic interventions such as flavonoid-based formulations before irreversible retinal damage occurs. Future interdisciplinary research integrating automated diagnostic screening with evidence-based natural product therapeutics may therefore offer a more comprehensive approach to diabetic retinopathy management.
Structure–Activity Relationship (SAR) Of Flavonoids
The pharmacological activity of flavonoids is closely governed by specific structural features of the flavonoid backbone, which collectively determine antioxidant potency, enzyme-binding affinity, and bioavailability:
Representative flavonoid constituents identified in Couroupita guianensis, including quercetin, kaempferol, rutin, and pelargonidin, exemplify these structural principles and collectively underpin the plant's broad-spectrum pharmacological activity. A more detailed understanding of these structure–activity relationships may guide future efforts toward semi-synthetic optimization or targeted isolation of the most pharmacologically potent constituents.
CURRENT RESEARCH GAPS
Despite encouraging preclinical evidence, several substantial gaps remain in the current body of literature concerning Couroupita guianensis and its flavonoid constituents, which must be addressed before clinical translation can be considered:
FUTURE PERSPECTIVES
Addressing the limitations outlined above will require a coordinated, multidisciplinary research agenda. Future investigations should prioritize the following directions:
CONCLUSION
Long-term hyperglycemia remains the principal driver of diabetic retinopathy progression, acting through interconnected oxidative stress and inflammatory signaling pathways that culminate in retinal microvascular damage and vision loss. Couroupita guianensis, by virtue of its rich flavonoid content, represents a promising medicinal plant capable of concurrently targeting multiple nodes within the diabetic and retinopathic disease cascade. Preclinical experimental evidence to date indicates meaningful antidiabetic activity, robust antioxidant protection, preservation of pancreatic β-cell function, and a plausible mechanistic basis for the prevention of retinal vascular injury. Taken together, these findings support the considerable pharmaceutical potential of Couroupita guianensis-derived flavonoids; however, realization of this potential will depend on rigorous future research addressing standardization, toxicology, pharmacokinetics, and ultimately, clinical validation in human subjects.
REFERENCES
Praveen Biradar*, Varshini M., D. Shakeela, Neela Madhav S., Ajay Kumar S. N., E. Gopinath, Plant-Derived Flavonoids from Couroupita Guianensis As Therapeutic Agents in Diabetes Mellitus & Diabetic Retinopathy: Mechanistic Insights, Pharmacological Potential & Future Perspectives: A Review, Int. J. Med. Pharm. Sci., 2026, 2 (7), 937-947. https://doi.org/10.5281/zenodo.21453117
10.5281/zenodo.21453117